Outset Medical Inc (OM)
3.135
+0.14
(+4.50%)
USD |
NASDAQ |
May 03, 16:00
3.135
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Enterprise Value: 78.31M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 78.31M |
| May 01, 2024 | 70.73M |
| April 30, 2024 | 54.57M |
| April 29, 2024 | 59.62M |
| April 26, 2024 | 48.00M |
| April 25, 2024 | 46.99M |
| April 24, 2024 | 55.58M |
| April 23, 2024 | 51.03M |
| April 22, 2024 | 44.97M |
| April 19, 2024 | 43.96M |
| April 18, 2024 | 40.43M |
| April 17, 2024 | 35.88M |
| April 16, 2024 | 31.84M |
| April 15, 2024 | 29.82M |
| April 12, 2024 | 30.33M |
| April 11, 2024 | 41.69M |
| April 10, 2024 | 43.71M |
| April 09, 2024 | 53.56M |
| April 08, 2024 | 54.57M |
| April 05, 2024 | 30.33M |
| April 04, 2024 | 24.77M |
| April 03, 2024 | 29.32M |
| April 02, 2024 | 28.31M |
| April 01, 2024 | 31.84M |
| March 28, 2024 | 38.91M |
| Date | Value |
|---|---|
| March 27, 2024 | 37.90M |
| March 26, 2024 | 37.90M |
| March 25, 2024 | 30.58M |
| March 22, 2024 | 27.30M |
| March 21, 2024 | 32.35M |
| March 20, 2024 | 38.91M |
| March 19, 2024 | 40.43M |
| March 18, 2024 | 27.80M |
| March 15, 2024 | 36.39M |
| March 14, 2024 | 36.39M |
| March 13, 2024 | 49.52M |
| March 12, 2024 | 49.52M |
| March 11, 2024 | 61.13M |
| March 08, 2024 | 75.78M |
| March 07, 2024 | 73.26M |
| March 06, 2024 | 68.20M |
| March 05, 2024 | 74.77M |
| March 04, 2024 | 79.82M |
| March 01, 2024 | 82.85M |
| February 29, 2024 | 85.88M |
| February 28, 2024 | 102.04M |
| February 27, 2024 | 118.21M |
| February 26, 2024 | 111.64M |
| February 23, 2024 | 114.67M |
| February 22, 2024 | 99.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.77M
Minimum
Apr 04 2024
2.507B
Maximum
Apr 30 2021
1.154B
Average
995.03M
Median
Dec 19 2022
Enterprise Value Benchmarks
| AngioDynamics Inc | 164.28M |
| Baxter International Inc | 29.41B |
| Allurion Technologies Inc | 106.03M |
| Perspective Therapeutics Inc | 1.008B |
| Xtant Medical Holdings Inc | 128.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -38.60M |
| Revenue (Quarterly) | 30.51M |
| Total Expenses (Quarterly) | 67.86M |
| EPS Diluted (Quarterly) | -0.77 |
| Gross Profit Margin (Quarterly) | 25.28% |
| Profit Margin (Quarterly) | -126.5% |
| Earnings Yield | -111.6% |
| Normalized Earnings Yield | -111.64 |